Umeå University's logo

umu.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Probabilistic classification of anti-SARS-CoV-2 antibody responses improves seroprevalence estimates
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, United Kingdom.
Department of Infectious Diseases, Karolinska University Hospital, Huddinge, Sweden.
Vise andre og tillknytning
2022 (engelsk)Inngår i: Clinical & Translational Immunology (CTI), E-ISSN 2050-0068, Vol. 11, nr 3, artikkel-id e1379Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Objectives: Population-level measures of seropositivity are critical for understanding the epidemiology of an emerging pathogen, yet most antibody tests apply a strict cutoff for seropositivity that is not learnt in a data-driven manner, leading to uncertainty when classifying low-titer responses. To improve upon this, we evaluated cutoff-independent methods for their ability to assign likelihood of SARS-CoV-2 seropositivity to individual samples. Methods: Using robust ELISAs based on SARS-CoV-2 spike (S) and the receptor-binding domain (RBD), we profiled antibody responses in a group of SARS-CoV-2 PCR+ individuals (n = 138). Using these data, we trained probabilistic learners to assign likelihood of seropositivity to test samples of unknown serostatus (n = 5100), identifying a support vector machines-linear discriminant analysis learner (SVM-LDA) suited for this purpose. Results: In the training data from confirmed ancestral SARS-CoV-2 infections, 99% of participants had detectable anti-S and -RBD IgG in the circulation, with titers differing > 1000-fold between persons. In data of otherwise healthy individuals, 7.2% (n = 367) of samples were of uncertain serostatus, with values in the range of 3-6SD from the mean of pre-pandemic negative controls (n = 595). In contrast, SVM-LDA classified 6.4% (n = 328) of test samples as having a high likelihood (> 99% chance) of past infection, 4.5% (n = 230) to have a 50–99% likelihood, and 4.0% (n = 203) to have a 10–49% likelihood. As different probabilistic approaches were more consistent with each other than conventional SD-based methods, such tools allow for more statistically-sound seropositivity estimates in large cohorts. Conclusion: Probabilistic antibody testing frameworks can improve seropositivity estimates in populations with large titer variability.

sted, utgiver, år, opplag, sider
John Wiley & Sons, 2022. Vol. 11, nr 3, artikkel-id e1379
Emneord [en]
antibody responses, antibody testing, COVID-19, probability, SARS-CoV-2, serology
HSV kategori
Identifikatorer
URN: urn:nbn:se:umu:diva-193709DOI: 10.1002/cti2.1379ISI: 000773551400002PubMedID: 35284072Scopus ID: 2-s2.0-85127258616OAI: oai:DiVA.org:umu-193709DiVA, id: diva2:1653906
Forskningsfinansiär
NIH (National Institutes of Health), 400 SUM1A44462‐02Wellcome trust, 107881Wellcome trust, 220788Swedish Research Council, 2017‐00968Tilgjengelig fra: 2022-04-25 Laget: 2022-04-25 Sist oppdatert: 2022-12-09bibliografisk kontrollert

Open Access i DiVA

fulltext(4412 kB)195 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 4412 kBChecksum SHA-512
4fac6e1aab4d0f29a864ae111da41f390fa7430cd99046a4cd00f7f82a08eeb592b58b3065a6b4021dbee271d40a36ae19cb4b205285a68f74031e160db9d40b
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMedScopus

Person

Vikström, LinneaForsell, Mattias N. E.

Søk i DiVA

Av forfatter/redaktør
Vikström, LinneaForsell, Mattias N. E.
Av organisasjonen
I samme tidsskrift
Clinical & Translational Immunology (CTI)

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 195 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 269 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf